Is “AGA is Genetic, So Nothing Can Be Done” Really True? — Reading the Real Power and Limits of Genetic Testing Through the Lens of Stem Cell Conditioned Media2026.07.10

“AGA runs in the family, so there’s nothing I can do about it” — this is a phrase we hear often in the clinic. When a patient has a strong family history of thinning hair, many enter a kind of half-resigned mindset the moment they notice their own shedding, thinking “it’s already decided.” But the genetics of AGA is not as simple as “fate,” and there is real room for environmental factors and therapeutic intervention. In recent years, regenerative treatment of the scalp using stem cell conditioned media has been added to clinical options, expanding the range of moves available even to those with high genetic risk. In this article, Dr. Moriwaki organizes how AGA inheritance actually works, what genetic testing can and cannot tell us, and how to translate genetic background into treatment design.

Key Points of This Article

・AGA is not caused by a single gene; it is a polygenic disease in which multiple SNPs accumulate to raise the risk of onset.

・The folk belief that “you can tell if you’ll go bald by looking at your maternal grandfather” has some basis in the AR-gene polymorphism on the X chromosome, but this is only one factor.

・Consumer AGA genetic tests mainly reveal AR sensitivity; they cannot predict age of onset or speed of progression.

・Even with high genetic risk, combining early intervention, lifestyle, and stem cell conditioned media leaves room to slow progression.

・Genetics decides the “starting line” of treatment; it is not a verdict deciding the “finish line.”

How Far Has AGA Genetics Been Elucidated?

AGA (androgenetic alopecia) used to be described in an oversimplified way as “determined by polymorphisms in the androgen receptor (AR) gene.” Recent genome-wide association studies (GWAS), however, have shown that more than 200 SNPs (single-nucleotide polymorphisms) are involved in AGA onset. In other words, AGA is not a single-gene disease but a “polygenic disease” in which many gene polymorphisms accumulate to shape risk.

Is “Look at Your Maternal Grandfather” True?

The folk belief that “baldness is inherited from the mother’s side” does have some biological basis. The AR (androgen receptor) gene, the single most important gene in AGA, lies on the X chromosome, and men inherit only one X chromosome — from their mother. AR polymorphisms are therefore strongly shaped by the maternal line. But this is only “one factor”: autosomal risk genes (such as the PAX1/FOXA2 region on chromosome 20) also contribute strongly, so the paternal side cannot be ignored either.

The Truth Is: It’s a Polygenic Disease

Our current understanding is that AGA is the overall product of “AR gene × many SNPs × environmental factors.” The reason age of onset and progression speed differ even within the same family is that the way these accumulate varies from person to person. A pattern like “my older brother has a thin crown in his 40s, but my forehead began receding in my mid-30s” can be explained by the individual “combination drawn” from genetics, plus lifestyle, stress, and whether or not therapeutic intervention took place.

How Far Can Genetic Testing Predict?

AGA genetic tests offered at pharmacies or by home kits are becoming widespread, but their results require careful interpretation.

What the Test Can Reveal

What a typical AGA genetic test examines is mainly the number of CAG repeats in the AR gene and specific SNPs. Shorter CAG repeats are associated with higher AR sensitivity, which tends to correlate with higher AGA risk. Some tests examine 5α-reductase polymorphisms as well and can estimate, to some extent, how well finasteride or dutasteride may work for that individual.

What the Test Cannot Reveal

On the other hand, genetic testing cannot predict “age of onset,” “speed of progression,” or the “final pattern of hair loss.” Even among people who receive the same “high-risk” result, some progress rapidly in their 30s while others show almost no change through their 60s. Only a small portion of the more than 200 SNPs found through GWAS are actually covered by consumer tests. It is essential to understand the limitation that “negative does not mean safe” and “positive does not mean you will definitely thin.”

Intervening in Genetic Risk Through the Lens of Stem Cell Conditioned Media

Genetics itself cannot be changed, but age of onset and speed of progression can definitely be shifted by environment and intervention. In particular, approaches that improve the “microenvironment of the hair follicle” carry meaning even for those at high genetic risk.

The Weight of Environmental Factors

Sleep, nutrition, stress, and the scalp environment also influence how gene switches are expressed (epigenetics). Chronic inflammation and oxidative stress damage the niche of follicle stem cells and act to accelerate AGA progression. Rather than giving up saying “I lost the genetic lottery,” the first step is to optimize the environmental variables that are within your control.

Stem Cell Conditioned Media as an Option

As a means of controlling AR-sensitivity-driven risk with oral and topical therapy while also improving the regenerative environment of the hair follicle itself, injection and drug-delivery approaches to the scalp using stem cell conditioned media have been added to the treatment options. The diverse growth factors it contains (IGF-1, HGF, VEGF, and others) and exosomes are thought to work in the direction of prolonging the anagen phase of the hair cycle through peri-follicular angiogenesis, anti-inflammatory action, and activation of dermal papilla cells. Even for those with genetically high AR sensitivity, continuously improving the follicle microenvironment leaves room to soften the curve of progression. Please also see our related hair-regeneration column list.

Designing Treatment Around Genetic Background

What matters most before receiving a genetic test is to decide in advance “how you will use the result.” A realistic guideline is: if the result is high risk, actively combine early intervention with oral, topical, and regenerative medicine; if the result is low risk, still keep up lifestyle habits and periodic monitoring. Regarding the overall approach to AGA treatment, the guidelines of the Japanese Dermatological Association are also a useful reference. Genetic risk is a “material for deciding the starting line” of treatment, not a “verdict deciding the finish line.” Even with the same genetic background, when you start intervening and how you maintain the follicle environment can change your hair volume a decade from now.

Frequently Asked Questions

Q. Should I take an AGA genetic test?

It is useful as a rough guide for deciding whether to start treatment early, but do not put excessive trust in the result. Consumer tests reveal only a small portion of genetic factors. It is important to interpret the results together with clinical findings and family history — the test alone does not determine a treatment plan.

Q. If my maternal grandfather went bald, does that mean I almost certainly will too?

It is true that the AR gene lies on the X chromosome and is more strongly influenced from the mother’s side, but AGA is a polygenic disease. Paternal genetics and environmental factors also come in, so we cannot say “you will definitely thin.” Rather, use it as information at the level of “your risk may be somewhat higher than average.”

Q. If genetic risk is high, can stem cell conditioned media still be expected to help?

What genetics determines is the “constitutional” part, such as AR sensitivity. Conditioned media works in the direction of improving the follicle microenvironment, so a certain role can be expected regardless of whether genetic risk is high or low. Combination with oral therapy is the basis, and it is not something that promises a complete cure on its own.

Q. From what age should genetic testing be considered?

AGA can progress even from the 20s. If your family history is strong, having a test in your early 20s can be a useful reference for deciding early intervention. That said, at the moment you become aware of shedding, seeing a physician takes priority.

Q. If the genetic test comes back as “low risk,” is it safe to feel reassured?

Unfortunately, we cannot make a definitive statement. Current consumer tests do not cover many of the risk SNPs found through GWAS. Please continue with regular scalp checks and lifestyle maintenance. Rather than reading “low risk” as “you can let your guard down,” it is more practical to read it as “you have a good window to bank progress through preventive intervention now.”

──────────────

Supervising Physician: Shin Moriwaki, M.D.

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate (U.S. Medical Licensing Qualification)

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt Available

Inquiries welcome via DM / LINE / Website / Phone.